1first year MBBS student at Datta Meghe Medical College, Shalinitai Meghe
Hospital and Research Centres, Nagpur, India.
2HOD Department of Biochemistry Datta Meghe Medical College,
Shalinitai Meghe Hospital and Research Centre, Nagpur, India.
3Department of Microbiology Jawaharlal Nehru Medical College, Datta Meghe I
nstitute of Medical Sciences Sawangi (Meghe), Wardha
Corresponding author email: Shibu142@gmail.com
Article Publishing History
Received: 28/03/2021
Accepted After Revision: 29/05/2021
Wether asthma constitutes a risk factor for coronavirus disease-2019 is unclear. This article aims to assess wether asthma, is associated with higher Covid-19 risk or severity in pediatric age group and provide a review, how did the pandemic impact the management of this chronic disease in the pediatric population. A systematic literature review was carried out on PubMed and Google Scholar under the following head – Covid-19, Paediatric population, Asthma, Management. Out of all the articles found 8 were short listed. Based on which this systematic review has been produced. The COVID-19 pandemic has been hovering since 2 years now and still it remains unclear wether it makes the condition of asthma worse specifically in the pediatric age group and the same unmitigated spread created countless difficulties for diagnosis of the same. This article elaborates on the same. There is barely any data available as of now pertaining the same issue therefore, initial concerns about children and young people with asthma being infected with the virus have not been found out or realised. Clearly, our understanding of the relationship between the infection and pediatric asthma still remains explorative. Studies are required beyond counting to lay our conclusions on the same.
Covid-19, Paediatric population, Asthma, Management